Quantcast

Latest Oragenics Inc. Stories

0037c1cac21fad0d36b924b1109372ed1
2004-11-30 12:00:00

ALACHUA, Fla. -- Oragenics Inc. plans to start human safety studies of its replacement therapy early next year, using a genetically modified bacteria to battle decay caused by naturally occurring microbes already in the mouth. The Food and Food and Drug Administration on Tuesday lifted a clinical hold on the tooth decay treatment. In a press release Tuesday, the Alachua, Fla.-based biotechnology company said the FDA approved a Phase I trial after reviewing the study's clinical design. "The...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related